Study Analyzes Factors Behind Affordable Modern Diabetes Medications in India

A study by Chennai diabetologists published in Diabetes Care examined how India maintains low pricing for modern diabetes treatments.

Affordability is supported by domestic pharmaceutical manufacturing, generic drug legislation, and preventive safeguards against patent evergreening.

Government initiatives have promoted local raw material production, with 26 previously imported molecules commencing domestic manufacture by 2025.